Roivant Buoys Anti-Infective Portfolio With Novel iNtRON Asset

 
• By Jung Won Shin
  
Agreement business handshake partnership deal as a solution strategy with a team coming together out of tangled twisted roads on to a bridge to find a common goal.
Roivant Licenses In Novel Korean Anti-infective • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia